Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Equine mask

a mask and equine technology, applied in the field of equine masks, can solve the problems of inability to use epinephrine, and inability to fully discharge, etc., and achieve the effect of reducing the risk of infection, and facilitating the attachment of the hors

Inactive Publication Date: 2002-05-16
FOLEY MARTIN P +1
View PDF0 Cites 14 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

0009] In carrying out the foregoing and other objects of the present invention we take advantage of the fact that horses are accustomed to having devices placed over their mouths and adjacent portions of the head, feedbags being common examples. We provide a mask covering the nostrils and mouth of a horse which is lightly sealed to the adjacent areas of the horse's head, but allowing a certain amount of air to pass under the seal along the horse's mouth, as this is comforting to the horse; FIG. 21 is a view generally similar to FIG. 6, but showing a modification using a nebulizer rather than a metered dose inhaler; and FIG. 22 is a fragmentary view showing a modification of a portion of FIG. 21. Either the mask is readily attached to the horse or other equine animal by means of attachments se

Problems solved by technology

Many people suffer breathing problems, particularly asthma, from allergic reactions.
Alternatively, wet materials, particularly molds often trigger asthmatic attacks.
However, epinephrine has undesirable side effects, and better medications have been developed, such as metaproterenol, and albuterol.
The metered dose inhalers do not themselves produce a sufficiently aerosolized form of medication to be highly effective.
The problem is particularly acute with horses that have to perform physically, such as race horses, working farm horses, etc.
Some little work has been done with nebulizers, but these have not been very effective.
Furthermore, it is believed that there is no anti-asthmatic medication with special efficacy in the equine family.
Further, it is believed that it will be many years before any such specific anti-asthmatic medication is developed.
The problem is to deliver anti-asthmatic medication to equine animals.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Equine mask
  • Equine mask
  • Equine mask

Examples

Experimental program
Comparison scheme
Effect test

first embodiment

[0053] Alternatives for First Embodiment Inhaler Attachment

[0054] A modification of the attachment of the mask to the inhaler is shown in FIG. 4, this being very similar to what is disclosed in the aforesaid Foley et al U.S. patent. Certain other parts are the same as those here to afore disclosed, and identified with similar numerals with the addition of the suffix a. The outlet fitting 72 includes a cylinder extending in the downstream direction, and having secured at the downstream end thereof inner and outer flanges 80 and 82, respectively, interconnected by a radial web 84. The portion 74a at the front end of the mask 38 is cylindrical rather than flared, and has an internal diameter to fit over the outside of the cylindrical portion 78, being recessed at 86 to fit over the flange 82, whereby the mask is anchored to the inhaler.

[0055] A further modification is shown in FIG. 5. Similar parts again are identified by like numerals, this time with the addition of the suffix b. In t...

second embodiment (figs.6-9)

[0056] b. Second Embodiment (FIGS. 6-9)

[0057] Another eariler preferred form of the invention is shown in FIGS. 6-9. The horse is identical, and portions of the invention are the same or similar to those heretofore shown and described, and in this instance are identified by like numerals with the addition of the suffix c.

[0058] The mask 36c is provided at the lower portion with a "dribble-section" or "slobbering cup" 88. Horses often sputter when relaxed, and this portion serves as a collecting place for sputtered saliva.

[0059] The two exhalation ports 46c are lowered slightly from their position in FIGS. 1 and 2, whereby the nostrils 90 of the horse are visible in FIG. 6. A strap 92 extends from two discrete locations at the top edge of the mask 38c, passing behind the horse's head immediately behind the ears 94. The strap is provided with what might be called a buckle section 96, with opposing portions having hook and loop fasteners (Viz., VELCRO).

[0060] The upper edge of the mask...

sixth embodiment (figs.14-16)

[0076] f. Sixth Embodiment (FIGS. 14-16)

[0077] A somewhat different form of the invention is shown in FIGS. 14-16. The numerals used for various portions of the horse and harness remain identical with those previously used. Insofar as portions of the mask are similar to those heretofore used, similar numerals are used with the addition of the suffix g. The form of the invention in FIGS. 14-16 is somewhat skeletonized compared with previous embodiments. Mask 38 includes a hollow body 168 with a tubular entrance end 170 extending thereinto. The cylindrical body 48g of the aerosolization chamber 50g plugs directly into the tubular entrance 170 of the hollow body 168. The single exhalation port 46g is mounted on the top or frontal portion of the hollow body. Hollow side branches 172 extend from the body to the vicinity of the horse's nostrils 90, and substantially cylindrical cups 174 extend therefrom to overlie the nostrils 90, thus establishing communication between aerosolizing chamb...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A mask is provided for administering medication, particularly asthmatic medication, to equine animals, particularly horses. The mask has a body that fits over the nostrils of the horse. An aerosolization chamber is secured to the body and opens into the interior thereof, and is supplied with misted medications such as from a metered dose inhaler, for inhalation by the animal. The mask and body is also provided with one or more exhalation ports, and a strap or band or the like for securing the body to the animals face overlying the nostrils.

Description

[0001] This application is a continuation of application Ser. No. 07 / 947,821, filed Sep. 24, 1992, which is incorporated herein by reference, which is a continuation-in-part of application Ser. No. 07 / 776,835, filed Oct. 15, 1991, which is now abandoned.[0002] Many people suffer breathing problems, particularly asthma, from allergic reactions. Asthma is frequently triggered by grasses, grains, and dust. Alternatively, wet materials, particularly molds often trigger asthmatic attacks. Much work has been done to ameliorate asthmatic attacks in human beings. Metered dose inhalers (MDI) have been developed which will deliver a metered does of medication upon depression of an outlet valve. Epinephrine was one of the first such anti-asthmatic drugs to be packaged in metered dose inhalers. However, epinephrine has undesirable side effects, and better medications have been developed, such as metaproterenol, and albuterol. These have a more direct action on the bronchi and do not have nearly...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61D7/04
CPCA61D7/04
Inventor FOLEY, MARTIN P.JENKINS, DAVID
Owner FOLEY MARTIN P
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products